Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Silo Pharma Inc (NQ: SILO ) 0.9626 +0.0076 (+0.80%) Streaming Delayed Price Updated: 3:58 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 88,787 Open 1.000 Bid (Size) 0.9320 (11) Ask (Size) 0.9558 (3) Prev. Close 0.9550 Today's Range 0.8922 - 1.020 52wk Range 0.8922 - 3.050 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSD June 26, 2024 Via Investor Brand Network Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety June 26, 2024 From Silo Pharma, Inc. Via GlobeNewswire Performance YTD -36.67% -36.67% 1 Month -18.42% -18.42% 3 Month -53.27% -53.27% 6 Month -38.88% -38.88% 1 Year -53.72% -53.72% More News Read More 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 11, 2024 Via Benzinga PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes on $2M Registered Direct Offering, Provides Update on SP-26 Ketamine Implant Therapeutic June 07, 2024 Via Investor Brand Network Why Silo Pharma Stock Is Down Over 30% June 05, 2024 Via Benzinga Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia June 07, 2024 From Silo Pharma, Inc. Via GlobeNewswire Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules June 06, 2024 From Silo Pharma, Inc. Via GlobeNewswire Crude Oil Rises 1%; Dollar Tree Shares Fall After Q1 Results June 05, 2024 Via Benzinga Exposures Fossil Fuels 12 Health Care Stocks Moving In Wednesday's Intraday Session June 05, 2024 Via Benzinga Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session June 05, 2024 Via Benzinga InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Registered Direct Offering Estimated to Reach $2M June 05, 2024 Via Investor Brand Network Gold Gains 1%; ISM Services PMI Surges In May June 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules June 05, 2024 From Silo Pharma, Inc. Via GlobeNewswire InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Pre-IND Submission for Proprietary Treatment for PTSD, Anxiety June 04, 2024 Via Investor Brand Network Exposures Product Safety Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety June 04, 2024 From Silo Pharma, Inc. Via GlobeNewswire Silo Pharma’s (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors June 04, 2024 Via AB Newswire Exposures Product Safety 12 Health Care Stocks Moving In Thursday's Intraday Session May 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 23, 2024 Via Benzinga PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Shares ‘Significant Development’ in Depression Study Showing Potential to Extend Remission Period, Prevent Relapse May 21, 2024 Via Investor Brand Network Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention May 21, 2024 From Silo Pharma, Inc. Via GlobeNewswire BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Announces Participation in FDA Event Exploring Emerging Therapeutic Interest in Ketamine May 14, 2024 Via Investor Brand Network Exposures Product Safety Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine May 14, 2024 From Silo Pharma, Inc. Via GlobeNewswire InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Shares Positive Results for PTSD Treatment April 23, 2024 Via Investor Brand Network Silo Pharma Announces Positive Results for Intranasal PTSD Treatment April 23, 2024 From Silo Pharma, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
